Literature DB >> 11312344

Structural consequences of cyclophilin A binding on maturational refolding in human immunodeficiency virus type 1 capsid protein.

L Dietrich1, L S Ehrlich, T J LaGrassa, D Ebbets-Reed, C Carter.   

Abstract

While several cellular proteins are incorporated in the human immunodeficiency virus type 1 virion, cyclophilin (CyP) A is the only one whose absence has been demonstrated to impair infectivity. Incorporation of the cytosolic protein results from interaction with a highly exposed Pro-rich loop in the N-terminal region of the capsid (CA) domain of the precursor polyprotein, Pr55(Gag). Even when prevented from interacting with CyP A, Pr55Gag still forms particles that proceed to mature into morphologically wild-type virions, suggesting that CyP A influences a postassembly event. The nature of this CyP A influence has yet to be elucidated. Here, we show that while CyP A binds both Gag and mature CA proteins, the two binding interactions are actually different. Tryptophan 121 (W121) in CyP A distinguished the two proteins: a phenylalanine substitution (W121F) impaired binding of mature CA protein but not of Gag. This indicates the occurrence of a maturation-dependent switch in the conformation of the Pro-rich loop. A structural consequence of Gag binding to CyP A was to block this maturational refolding, resulting in a 24-kDa CA protein retaining the immature Pro-rich loop conformation. Using trypsin as a structure probe, we demonstrate that the conformation of the C-terminal region in mature CA is also a product of maturational refolding. Binding to wild-type CyP A altered this conformation, as indicated by a reduction in the accessibility of Cys residue(s) in the region to chemical modification. Hence, the end result of binding to CyP A, whether the Pro-rich loop is in the context of Gag or mature CA protein, is a structurally modified mature CA protein. The postassembly role of CyP A may be mediated through these modified mature CA proteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11312344      PMCID: PMC114227          DOI: 10.1128/JVI.75.10.4721-4733.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid.

Authors:  T R Gamble; F F Vajdos; S Yoo; D K Worthylake; M Houseweart; W I Sundquist; C P Hill
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

2.  Absconding with the chaperone: essential cyclophilin-Gag interaction in HIV-1 virions.

Authors:  J Luban
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

3.  Crystal structure of dimeric HIV-1 capsid protein.

Authors:  C Momany; L C Kovari; A J Prongay; W Keller; R K Gitti; B M Lee; A E Gorbalenya; L Tong; J McClure; L S Ehrlich; M F Summers; C Carter; M G Rossmann
Journal:  Nat Struct Biol       Date:  1996-09

4.  A method for determining transmembrane protein structure.

Authors:  P C Jones; A Sivaprasadarao; D Wray; J B Findlay
Journal:  Mol Membr Biol       Date:  1996 Jan-Mar       Impact factor: 2.857

5.  Constitutive production of nonenveloped human immunodeficiency virus type 1 particles by a mammalian cell line and effects of a protease inhibitor on particle maturation.

Authors:  L M Babé; C S Craik
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

6.  Structural analysis of human immunodeficiency virus type 1 Gag protein interactions, using cysteine-specific reagents.

Authors:  J McDermott; L Farrell; R Ross; E Barklis
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

7.  Partitioning of HIV-1 Gag and Gag-related proteins to membranes.

Authors:  L S Ehrlich; S Fong; S Scarlata; G Zybarth; C Carter
Journal:  Biochemistry       Date:  1996-04-02       Impact factor: 3.162

8.  The major homology region of the HIV-1 gag precursor influences membrane affinity.

Authors:  D Ebbets-Reed; S Scarlata; C A Carter
Journal:  Biochemistry       Date:  1996-11-12       Impact factor: 3.162

9.  Structure of the amino-terminal core domain of the HIV-1 capsid protein.

Authors:  R K Gitti; B M Lee; J Walker; M F Summers; S Yoo; W I Sundquist
Journal:  Science       Date:  1996-07-12       Impact factor: 47.728

10.  Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription.

Authors:  D Braaten; E K Franke; J Luban
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more
  8 in total

1.  Magic angle spinning NMR reveals sequence-dependent structural plasticity, dynamics, and the spacer peptide 1 conformation in HIV-1 capsid protein assemblies.

Authors:  Yun Han; Guangjin Hou; Christopher L Suiter; Jinwoo Ahn; In-Ja L Byeon; Andrew S Lipton; Sarah Burton; Ivan Hung; Peter L Gor'kov; Zhehong Gan; William Brey; David Rice; Angela M Gronenborn; Tatyana Polenova
Journal:  J Am Chem Soc       Date:  2013-11-13       Impact factor: 15.419

2.  Regulation of nuclear translocation of the Myb1 transcription factor by TvCyclophilin 1 in the protozoan parasite Trichomonas vaginalis.

Authors:  Hong-Ming Hsu; Chien-Hsin Chu; Ya-Ting Wang; Yu Lee; Shu-Yi Wei; Hsing-Wei Liu; Shiou-Jeng Ong; Chinpan Chen; Jung-Hsiang Tai
Journal:  J Biol Chem       Date:  2014-05-15       Impact factor: 5.157

3.  trans-Complementation rescue of cyclophilin A-deficient viruses reveals that the requirement for cyclophilin A in human immunodeficiency virus type 1 replication is independent of its isomerase activity.

Authors:  Andrew C S Saphire; Michael D Bobardt; Philippe A Gallay
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  The cysteine residues of HIV-1 capsid regulate oligomerization and cyclophilin A-induced changes.

Authors:  Marjorie Bon Homme; Carol Carter; Suzanne Scarlata
Journal:  Biophys J       Date:  2004-12-30       Impact factor: 4.033

5.  Multiple Roles of SARS-CoV-2 N Protein Facilitated by Proteoform-Specific Interactions with RNA, Host Proteins, and Convalescent Antibodies.

Authors:  Corinne A Lutomski; Tarick J El-Baba; Jani R Bolla; Carol V Robinson
Journal:  JACS Au       Date:  2021-06-15

6.  Structural, biochemical, and in vivo characterization of the first virally encoded cyclophilin from the Mimivirus.

Authors:  Vu Thai; Patricia Renesto; C Andrew Fowler; Darin J Brown; Tara Davis; Wanjun Gu; David D Pollock; Dorothee Kern; Didier Raoult; Elan Z Eisenmesser
Journal:  J Mol Biol       Date:  2007-08-29       Impact factor: 5.469

7.  Human immunodeficiency virus type 1 N-terminal capsid mutants containing cores with abnormally high levels of capsid protein and virtually no reverse transcriptase.

Authors:  Shixing Tang; Tsutomu Murakami; Naiqian Cheng; Alasdair C Steven; Eric O Freed; Judith G Levin
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

8.  Cyclosporine inhibits a direct interaction between cyclophilins and hepatitis C NS5A.

Authors:  Fiona Fernandes; Israr-ul H Ansari; Rob Striker
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.